Food and Drug Administration: 31 batches of Chinese medicine drink tablets unqualified ordered the relevant enterprises to rectify

The State Administration of Food and Drug Administration issued a notice on the 10th, marked as Anhui Jishun Chinese Medicine Drinking Tablets Co., Ltd and other 29 enterprises produced 31 batches of Chinese medicine tablets unqualified The relevant provincial food and drug regulatory departments have taken control measures such as seizure and seizure, requiring enterprises to suspend the sale of products, recall products, and carry out rectification. According to the notice, non-conforming products include: marked as Anhui Jishun Chinese Medicine Drinking Tabletco Co., Ltd., Anhui Shangde Chinese Medicine Drinking Tabletco Co., Ltd., Jiangxi Shengkang Pharmaceutical Co., Ltd., Guangdong Lianfeng Chinese Medicine Drink ingleping tablets Co., Ltd and other enterprises produced 20 batches of sand kernels unqualified Nonconforming items include traits and content determination. Labeled as Anhui Jiezhu Biochemistry Co , Ltd production of 1 batch of sand kernel (net sand kernel) is not qualified Nonconforming items are content determination. Marked as Jiangsu Fuyuan Chinese Medicine Drinking Tabletco Co., Ltd., Anhui Poly-Grass Chinese Medicine Drinking Tablet co., Ltd., Anhui Chinese medicine drink tablets limited liability company, Beijing Shizhentang (Ichang) Pharmaceutical Co., Ltd and other enterprises produced 10 batches of the mother is not qualified Nonconforming items include moisture and content determination. The General Administration of Food and Drug Supervision requires the provincial food and drug supervision and administration department where the relevant units are located to file a case for investigation into the illegal acts of producing and selling non-conforming drugs in accordance with the relevant provisions, and to make public the results of the treatment of the units concerned in the production and sale of non-conforming drugs within three months. Source: Xinhua Original title: General Administration of Food and Drug Administration: 31 batches of Chinese medicine tablets unqualified
latest update: 11/11 09:55